Table 10.
The sensitivity, specificity, and estimated probability of having severe post-operative pain for He−−ADSS score (the most severe post-operative pain scores were used to perform the above analyses)
| He−−ADSS score | Number | Sensitivity | Specificity | Estimated probability of having moderate to severe post-operative pain |
|---|---|---|---|---|
| 0 | 396 | 1 | 0 | 0.43 |
| 1 | 122 | 0.76 | 0.37 | 0.48 |
| 2 | 361 | 0.67 | 0.47 | 0.54 |
| 3 | 253 | 0.39 | 0.75 | 0.60 |
| 4 | 35 | 0.18 | 0.93 | 0.65 |
| 5 | 106 | 0.15 | 0.94 | 0.70 |
| 6 | 33 | 0.04 | 0.98 | 0.75 |
| 8 | 1 | 0.002 | 1 | 0.83 |
The combined BC-1 and BC-2 patient cohort did not have patients with a score of 7, when CSH was excluded. The BRUISE-Control He−−ADSS and He++ADSS scores post-operative pain risk score were developed based on the final risk prediction model (He, CSH; A, age; D, de novo surgery; S, slim—BMI <20 kg/m2; and S, sex—female).
BC-1, BRUISE CONTROL Trial 1; BC-2, BRUISE CONTROL Trial 2; BMI, body mass index; CSH, clinically significant haematoma.